--- title: "Pre-market hot trades in US stocks: Eshallgo pre-market down 9.57%; MKS pre-market up 8.31%" type: "News" locale: "en" url: "https://longbridge.com/en/news/285515536.md" description: "Eshallgo pre-market down 9.57%; MKS pre-market up 8.31%; Global Engine pre-market up 58.78%; agilon health pre-market up 45.49%; Octave Specialty pre-market up 37.91%" datetime: "2026-05-07T08:57:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285515536.md) - [en](https://longbridge.com/en/news/285515536.md) - [zh-HK](https://longbridge.com/zh-HK/news/285515536.md) --- # Pre-market hot trades in US stocks: Eshallgo pre-market down 9.57%; MKS pre-market up 8.31% **Popular Pre-Market Trades in US Stocks** Eshallgo is down 9.57% in pre-market trading. There have been no significant news recently; trading is active with clear capital flows. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news MKS is up 8.31% in pre-market trading. Based on recent key news: 1. On May 6, MKS announced its first-quarter financial report, with revenue of $1.078 billion, exceeding market expectations of $1.046 billion, and a net profit of $84 million, an increase compared to the same period last year. The better-than-expected financial report drove the stock price up. Source: Reuters 2. On May 6, MKS announced strong demand for its AI and semiconductors, driving revenue and earnings above guidance, and expects continued growth in revenue and earnings in the second quarter. This optimistic outlook further boosts market confidence. Source: MKS Inc. SEC announcement 3. On May 6, analysts gave MKS an average rating of "Buy," with a 12-month target price of $307.50, which is 6.9% higher than the closing price on May 5. Analysts' positive ratings support the stock price increase. Source: Reuters Strong demand in the semiconductor industry drives stock price up. **Top Gainers in Pre-Market Trading in US Stocks** Global Engine is up 58.78% in pre-market trading. There have been no significant news recently; trading is active with clear capital flows. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news Agilon Health is up 45.49% in pre-market trading. Based on recent key news: 1. On May 6, Agilon Health reported a net income of $49 million for the first quarter, far exceeding market expectations of $11.6 million. Adjusted EBITDA was $54 million, also higher than the expected $34.9 million. This performance drove the stock price significantly up. Source: Reuters 2. On May 4, JP Morgan downgraded Agilon Health's rating from "Neutral" to "Underweight," with a target price of $21. The brokerage pointed out that healthcare utilization remains high, and execution risks are still significant, requiring management to rebuild credibility. Despite the downgrade, the stock price still rose. Source: Reuters 3. On May 6, Agilon Health released original content via Business Wire, emphasizing improvements in its data and forecasting capabilities, as well as enhancements in operational processes, which help manage healthcare costs. Source: Business Wire The healthcare industry faces challenges with high healthcare utilization. Octave Specialty is up 37.91% in pre-market trading. Based on recent key news: 1. On May 6th, Octave Specialty Group announced its Q1 2026 financial report, showing a net premium growth of 80%, which significantly boosted the stock price. The company's report indicated that despite an earnings per share of -$0.13, the substantial growth in net premiums enhanced market confidence, leading to a pre-market increase of 37.91% in the stock price. Source: Business Wire 2. On May 6th, analysts rated Octave Specialty Group as "Buy," predicting a 12-month price target of $13.50, which is 219.9% higher than the closing price of $4.22 on May 6th. This optimistic analyst rating further propelled the stock price increase. Source: Reuters 3. Following the release of Octave Specialty Group's financial report on May 6th, market expectations for its future growth potential improved, leading investors to actively buy in. Although the earnings per share fell short of expectations, the growth in net premiums and analysts' optimistic forecasts jointly drove the stock price up. Source: Business Wire The insurance industry shows significant net premium growth, and the market is optimistic ### Related Stocks - [EHGO.US](https://longbridge.com/en/quote/EHGO.US.md) - [MKSI.US](https://longbridge.com/en/quote/MKSI.US.md) - [GLE.US](https://longbridge.com/en/quote/GLE.US.md) - [AGL.US](https://longbridge.com/en/quote/AGL.US.md) - [OSG.US](https://longbridge.com/en/quote/OSG.US.md) ## Related News & Research - [Top MKS Insider Makes Major Move With Fresh Stock Sale](https://longbridge.com/en/news/286500206.md) - [ZAWYA: University of Sharjah’s My FarmWell application wins UAE Society of Engineers Excellence and Creative Engineering Award](https://longbridge.com/en/news/286879017.md) - [How Investors May Respond To American Healthcare REIT (AHR) Cutting 2026 Profit Outlook After Q1 Results](https://longbridge.com/en/news/286866277.md) - [Twin Capital Management Inc. Grows Stock Position in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/287213128.md) - [Assessing MillerKnoll (MLKN) Valuation After New EIR Healthcare Partnership In Prefabricated Clinics](https://longbridge.com/en/news/286684089.md)